The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Thyroid Cancer Diagnostics Market During 2026–2030?
The market size for thyroid cancer diagnostics has exhibited substantial growth in recent times. The market is predicted to expand from $3.15 billion in 2025 to $3.34 billion in 2026, progressing at a compound annual growth rate (CAGR) of 6.0%. This historical growth can be ascribed to several factors, including the rising incidence of thyroid nodules, broader access to ultrasound imaging, enhanced biopsy methods, the expansion of cancer diagnostic laboratories, and increasing clinical awareness regarding thyroid cancers.
The thyroid cancer diagnostics market is projected to experience substantial expansion in the upcoming years. This market is anticipated to reach a value of $4.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.2%. The expansion during this forecast period can be primarily attributed to several factors, including the increasing integration of AI-assisted imaging diagnostics, a surging need for personalized oncology solutions, the broadening of molecular testing panels, heightened investments in early cancer detection, and a stronger emphasis on precision diagnostics. Key developments anticipated in this period encompass a rise in molecular diagnostic techniques, greater uptake of imaging-based screening methods, enhanced integration of genetic testing, the broadening of early detection initiatives, and improvements in diagnostic accuracy and speed.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12030&type=smp
What Underlying Factors Are Accelerating The Growth Of The Thyroid Cancer Diagnostics Market?
The escalating prevalence of thyroid cancer is a significant factor propelling the expansion of the thyroid cancer diagnostic market. Thyroid cancer itself is a condition impacting the thyroid gland, which is situated near the throat’s base and is responsible for producing hormones vital for regulating various bodily functions, including temperature, heart rate, blood pressure, and weight. Thyroid cancer diagnostics are crucial for identifying the disease through early detection, thereby helping to enhance treatment results. This rising incidence of thyroid cancer directly contributes to an increased demand within the diagnostic market. For instance, data from September 2023, based on a report from the American Cancer Society, a US-based non-profit organization, projected approximately 43,720 new cases of thyroid cancer for that year, with 12,540 cases among men and 31,180 among women. The report also estimated around 2,120 deaths from thyroid cancer in the same year, split between 970 men and 1,150 women. Consequently, the increasing prevalence of thyroid cancer is a major force driving the thyroid cancer diagnostic market.
How Are The Various Segments Of The Thyroid Cancer Diagnostics Market Categorized?
The thyroid cancer diagnostics market covered in this report is segmented –
1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Types
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users
Subsegments:
1) By Imaging Test: Ultrasound Imaging, Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, Radioactive Iodine Scans
2) By Blood Test: Thyroid Function Tests, Tumor Marker Tests, Genetic Testing For Thyroid Cancer
3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy
4) By Other Test Type: Molecular Diagnostics, Immunohistochemistry Tests, Histopathological Analysis
How Are Trends Impacting The Thyroid Cancer Diagnostics Market?
Leading companies active in the thyroid cancer diagnostic market are developing innovative solutions, such as RNA sequencing tests, to enhance the accuracy of cancer fusion detection across various solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that facilitates the analysis of the quantity and sequence of RNA in a sample, providing insights into gene expression and the overall transcriptome. For example, in May 2024, Foundation Medicine, Inc., a US-based biotechnology company, announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test offers fusion reporting for all solid tumors and may prove particularly useful in identifying fusions in cancers such as non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.
Which Major Firms Influence Developments In The Thyroid Cancer Diagnostics Market?
Major companies operating in the thyroid cancer diagnostics market are General Electric, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Toshiba Corporation, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Agilent Technologies Inc., Hologic Inc., Illumina Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc., Interpace Biosciences, Guardant Health, BillionToOne, Canon Inc., Beckman Coulter Inc.
Read the full thyroid cancer diagnostics market report here:
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report
Which Region Is Projected To Dominate The Thyroid Cancer Diagnostics Market During The Forecast Period?
North America was the largest region in the thyroid cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Thyroid Cancer Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12030&type=smp
Browse Through More Reports Similar to the Global Thyroid Cancer Diagnostics Market 2026, By The Business Research Company
Thyroid Function Test Global Market Report
https://www.thebusinessresearchcompany.com/report/thyroid-function-test-global-market-report
Cancer Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Thyroid Cancer Drugs Global Market Report
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model